Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples